ALIBABA-CLOUD
As the digital technology and intelligence backbone of Alibaba Group, Alibaba Cloud is experiencing continuous growth alongside its customers across different parts of the world. Over the years, it has made relentless efforts to serve clients from every industry, helping them accelerate their business development and navigate the challenges of these volatile times.
Cloud computing and AI technology have been shown to be the cornerstone for businesses seeking to be fully equipped in the digital era, especially following the global outbreak of COVID-19. At the 12th Apsara Conference: Leap into the Future of Digital Intelligence, customers from various sectors, including aviation, leisure and hospitality, education, and e-commerce and retail, share their growth and success stories achieved together with Alibaba Cloud.
“It is our utmost pleasure to see our customers experience a seamless transition into more digitalised operations,” said Selina Yuan, President for International Business, Alibaba Cloud Intelligence. “As a leading global cloud service provider, we take pride in supporting organizations leverage the advantages of our trusted cloud and AI technology, as they fully unlock the potential of their businesses and develop sustainable growth with us. We will continue to enhance our products and services as we leap into the future of digital intelligence.”
Soar higher
In the face of the complex challenges imposed by the spread of the COVID-19 pandemic and the resulting global travel restrictions, Garuda Indonesia (Garuda), the flag carrier of Indonesia that has been providing air transportation for the last 70 years, has chosen Alibaba Cloud as its trusted cloud service provider, as it is determined to implement digital transformation solutions that will enhance its agility and competitiveness in the aviation industry through improved, reliable and highly efficient IT operations.
Thanks to Alibaba Cloud’s robust database and network technology, as well as its IT architecture design service and advice on resource optimization, the airline has been able to significantly improve the performance and service reliability of its core applications, ranging from ticketing, onboarding, and crew management to customer membership management. Since the migration of its business-critical applications to Alibaba Cloud, Garuda has seen great network latency reduction and improved cost efficiency. The airline also takes a shorter time to release and deploy a new application and has enhanced the efficiency of its overall application operations.
Skip the queue
In Malaysia, Resorts World Genting’s upcoming outdoor theme park Genting SkyWorlds will adopt the Advanced Virtual Queue (VQ) Solution powered by Alibaba Cloud to enhance the customer experience. The VQ Solution is a comprehensive system that leverages Artificial Intelligence (AI) and integrates five algorithm modules – Dynamic VQ Slot Prediction, Dynamic Gamification Management, Itinerary Planning, Incentive Recommendation and Crowd Analysis and Prediction. These modules combine to enable more efficient crowd management and to reduce waiting times dynamically.
The solution will allow visitors to plan their entire experience from start to finish before they even reach the theme park. Visitors will be able to download the Genting SkyWorlds’ VQ Mobile App and purchase their tickets online at their convenience. Once the tickets are booked, the VQ Mobile App will allow visitors to plan their itinerary or provide them with an alternative optimised recommended itinerary to offer them a customised experience based on their preferences.
Learn without barriers
Rooted in Singapore, I Can Read (ICR) is an English literacy education service provider for kindergarten and elementary school students across 200 centers and schools in Asia and the Middle East. The organization promotes a uniquely structured curriculum to help children overcome difficulties in reading. One of the biggest challenges faced by the company during the COVID-19 pandemic was the closure of its learning centers in markets where face-to-face classes were prohibited. When trying to move the classes online, ICR encountered several technical barriers – for example, unstable Internet connectivity, the lack of a sound cloud infrastructure, and the need to manually migrate its student database to the designated e-learning platform and re-create more than 7,000 timetables.
To cope with these difficulties, ICR turned to Alibaba Cloud for support. By implementing relevant solutions, such as database storage on cloud and SMS service, the company managed to engage regional customers better with timelier updates on class changes and subsequent arrangements. This has effectively helped the company to stay focused on its business mission of delivering education through both online and offline channels.
Integrate the marketplace, offline and online
WEMART is one of the largest Asian supermarket chains in the Middle East. Its bricks and mortar storefronts have been seriously affected by the COVID-19 pandemic, while its online business volume has increased sharply, pressuring the company to better consolidate its offline and online resources and accelerate its digital transformation.
To power its next phase of growth, WEMART chose to tie up with Alibaba Cloud, which offered a comprehensive online-to-offline shopping solution that combines the strengths of an in-store experience with digital marketing, supporting the operation flow by managing payment gateways, transaction processing and customer membership. In addition, the customer experience was enhanced by other features that came with the solution. For example, the AliMe chatbot, an AI-powered virtual assistant, can handle 60-70% of consumer queries and after-sales service requests on a 24/7 basis, narrowing the communication gap between the retailer and its buyers and greatly improving both operational efficiency and consumer responsiveness.
About Alibaba Cloud
Established in 2009, Alibaba Cloud (alibabacloud.com), the digital technology and intelligence backbone of Alibaba Group, is among the world’s top three IaaS providers, according to Gartner. It is also the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and public services. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200917006047/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Natus Sensory Appoints Arne Boye Nielsen to Board of Directors8.1.2026 08:00:00 CET | Press release
Natus Sensory, a global leader in sensory and diagnostic solutions, today announced the appointment of Arne Boye Nielsen to its Board of Directors, effective January 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107392331/en/ Arne Boye Nielsen Arne brings more than 30 years of executive leadership experience in diagnostics and medical technology, most notably as President of Demant Diagnostics, where he built and scaled the business into a global leader over three decades. During his tenure, Arne played a central role in shaping Demant Diagnostics’ long-term strategy, portfolio expansion, and international growth, establishing it as a cornerstone of Demant’s global healthcare footprint. In addition to his executive leadership background, Arne brings extensive board experience. His deep expertise across diagnostics, governance, and value creation will further strengthen Natus Sensory’s Board as the company contin
4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics8.1.2026 07:30:00 CET | Press release
FDA IND clearance enabling the worldwide expansion of the INFLAM MOTION Phase 2a trial, involving major U.S. sites Advancing the first clinical proof of concept in OA with a first-in-class intra-articular GLP-1 agonist A holistic clinical strategy design establishing the foundation for a future accelerated approval pathway 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for 4P004, enabling the expansion of the Phase 2a INFLAM MOTION clinical trial into the United States (US). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260107798042/en/ 4Moving Biotech (4MB), a clinical stage biotechnology company developing next-generation, disease-modifying therapies for osteoarthritis (OA), today announced that the U.S. F
Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo®in France, Denmark, Iceland, Sweden, Finland and Norway8.1.2026 07:30:00 CET | Press release
The agreement builds on Organon’s cardiovascular disease portfolio, leveraging expertise to expand access to new treatments for patients with dyslipidemia, especially statin-intolerant patients.This collaboration addresses a critical gap in care that disproportionately affects women, who are at a 47% higher risk of developing statin intolerance compared to men.i Organon today announced that it has entered into an agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid) in France, Denmark, Iceland, Sweden, Finland and Norway. Nilemdo® is a new, first-in-class drug indicated for patients with high cholesterol and cardiovascular disease risk. It provides an alternative treatment for patients that cannot be treated effectively with statins.ii “This collaboration combines Organon’s commercial agility with Daiichi Sankyo’s expertise in cardiovascular innovation to bring Nilemdo® to patients in France, Denmark, Iceland, Sweden, Finland and Norway,” says Thibault Crosnie
Prodapt Earns ISO 42001 Certification, the New Global Benchmark for Responsible Enterprise AI8.1.2026 07:00:00 CET | Press release
Prodapt today announced that it has been awarded the ISO 42001 certification, the world’s first and the only global standard for AI Management Systems (AIMS). Marking a significant milestone in its journey, Prodapt is setting a higher benchmark to deliver secure, ethical, and scalable AI for global enterprises. ISO 42001 lays a rigorous framework for governing AI across strategy, technology, and operations. The certification, awarded by an independent accredited body, validates Prodapt’s enterprise-grade AI management framework, including executive-led oversight, strong technology foundations, and disciplined operational processes. These measures ensure AI systems are responsibly designed, deployed, monitored, and evolved throughout their lifecycle. The evaluation emphasizes risk management, ethical AI practices, transparency, and scalability, confirming Prodapt’s ability to proactively identify and mitigate risks while ensuring accountability in AI-driven outcomes. Human-in-the-loop c
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference8.1.2026 07:00:00 CET | Press release
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th Annual Healthcare Conference on Thursday, January 15. The company’s presentation will begin at 9:30 am PT/12:30 am ET/6:30 am CET. The presentation will focus on the company’s lead product, nizubaglustat, a potential treatment for rare lysosomal storage disorders with neurological involvement including GM1/GM2 gangliosidoses and Niemann-Pick type C disease ((NPC). Two pivotal Phase 3 studies investigating nizubaglustat in GM1/GM2 gangliosidoses and NPC are currently enrolling, with data expected in 2027. The studies build on positive data from a robust clinical program including the Phase 2 RAINBOW study and the PRONTO natural history study. The Phase 3 studies are financed following the company’s successful completion of €132 million series B round completed in 1H 2025. About nizubaglust
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom